Search

Author/Creator Wang, Zhanjian

1. Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial. (2nd November 2022)

Authors:
Yao, Jun; Guo, Xiaohui; Sun, Li; Han, Ping; Lv, Xiaofeng; Zhang, Xiuzhen; Mo, Zhaohui; Yang, Wenying; Zhang, Lihui; Wang, Zhanjian; Zhu, Lvyun; Li, Quanmin; Yang, Tao; Wang, Wenbo; Xue, Yaoming; Shi, Yongquan; Lu, Juming; Peng, Yongde; Zhang, Fan; Yan, Dewen
Journal:
Current medical research and opinion
Issue:
Volume 38:Number 11(2022)
Page Start:
1797
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Subject‐driven titration of biphasic insulin aspart 30 twice daily is non‐inferior to investigator‐driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open‐label, parallel‐group, multicenter trial. Issue 1 (25th May 2015)

Authors:
Yang, Wenying; Zhu, Lvyun; Meng, Bangzhu; Liu, Yu; Wang, Wenhui; Ye, Shandong; Sun, Li; Miao, Heng; Guo, Lian; Wang, Zhanjian; Lv, Xiaofeng; Li, Quanmin; Ji, Qiuhe; Zhao, Weigang; Yang, Gangyi
Journal:
Journal of diabetes investigation
Issue:
Volume 7:Issue 1(2016:Feb.)
Page Start:
85
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗